These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 19092267

  • 1. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.
    Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS, Organizing Committee of Japan-Korea Liver Symposium.
    Oncology; 2008; 75 Suppl 1():13-6. PubMed ID: 19092267
    [Abstract] [Full Text] [Related]

  • 2. Current status of liver diseases in Korea: hepatocellular carcinoma.
    Song IH, Kim KS.
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S50-9. PubMed ID: 20037280
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA, London WT.
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [Abstract] [Full Text] [Related]

  • 4. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan.
    Taura N, Hamasaki K, Nakao K, Ichikawa T, Nishimura D, Goto T, Fukuta M, Kawashimo H, Miyaaki H, Fujimoto M, Kusumoto K, Motoyoshi Y, Shibata H, Inokuchi K, Eguchi K.
    Oncol Rep; 2006 Oct; 16(4):837-43. PubMed ID: 16969503
    [Abstract] [Full Text] [Related]

  • 5. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC, Tong MJ.
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [Abstract] [Full Text] [Related]

  • 6. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
    Sypsa V, Touloumi G, Tassopoulos NC, Ketikoglou I, Vafiadis I, Hatzis G, Tsantoulas D, Akriviadis E, Delladetsima J, Demonakou M, Hatzakis A.
    J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma - United States, 2001-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 May 07; 59(17):517-20. PubMed ID: 20448528
    [Abstract] [Full Text] [Related]

  • 8. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA.
    Mutat Res; 2008 May 07; 659(1-2):176-84. PubMed ID: 18346933
    [Abstract] [Full Text] [Related]

  • 9. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P, Pacholczyk M, Łagiewska B, Adadyński L, Wasiak D, Kwiatkowski A, Chmura A, Czerwiński J.
    Przegl Epidemiol; 2006 May 07; 60(4):731-40. PubMed ID: 17682755
    [Abstract] [Full Text] [Related]

  • 10. [Hepatocellular carcinoma in Korea: introduction and overview].
    Park JW.
    Korean J Gastroenterol; 2005 Apr 07; 45(4):217-26. PubMed ID: 15843747
    [Abstract] [Full Text] [Related]

  • 11. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
    Romano PR, McCallus DE, Pachuk CJ.
    Oncogene; 2006 Jun 26; 25(27):3857-65. PubMed ID: 16799627
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
    Seeff LB, Hoofnagle JH.
    Oncogene; 2006 Jun 26; 25(27):3771-7. PubMed ID: 16799618
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus infection and hepatocellular carcinoma.
    Blonski W, Reddy KR.
    Clin Liver Dis; 2008 Aug 26; 12(3):661-74, x. PubMed ID: 18625433
    [Abstract] [Full Text] [Related]

  • 14. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
    Nguyen VT, Razali K, Amin J, Law MG, Dore GJ.
    J Gastroenterol Hepatol; 2008 Jun 26; 23(6):922-9. PubMed ID: 17608637
    [Abstract] [Full Text] [Related]

  • 15. Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan.
    Mizokami M, Tanaka Y.
    Cancer Chemother Pharmacol; 2004 Sep 26; 54 Suppl 1():S83-6. PubMed ID: 15316753
    [Abstract] [Full Text] [Related]

  • 16. Present trends in Japan with regard to epidemiology and clinical features of hepatocellular carcinoma.
    Ohto M, Ebara M, Sugiura N, Yoshikawa M.
    Ital J Gastroenterol; 1992 Sep 26; 24(3):144-5. PubMed ID: 1314115
    [Abstract] [Full Text] [Related]

  • 17. Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan.
    Ishiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S, JPHC Study Group.
    Eur J Cancer Prev; 2009 Feb 26; 18(1):26-32. PubMed ID: 19077561
    [Abstract] [Full Text] [Related]

  • 18. Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination.
    Lee CL, Hsieh KS, Ko YC.
    Cancer Epidemiol Biomarkers Prev; 2003 Jan 26; 12(1):57-9. PubMed ID: 12540504
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
    Nguyen VT, Law MG, Dore GJ.
    J Viral Hepat; 2009 Jul 26; 16(7):453-63. PubMed ID: 19302335
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.
    Roberts SK, Kemp W.
    J Gastroenterol Hepatol; 2007 Feb 26; 22(2):191-6. PubMed ID: 17295870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.